Constantine Stratakis is a Medical Genetics specialist and a Gastroenterologist in Bethesda, Maryland. Dr. Stratakis is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Cushing's disease, Neuroendocrine Tumor, Gastrointestinal Stromal Tumor, Orchiectomy, and Hormone Replacement Therapy (HRT).

Sekwon Jang is a Hematologist Oncology specialist and an Oncologist in Falls Church, Virginia. Dr. Jang is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Cutaneous T-Cell Lymphoma (CTCL), and Squamous Cell Skin Carcinoma. Dr. Jang is currently accepting new patients.

Peter Learn is a General Surgeon and a Surgical Oncologist in Falls Church, Virginia. Dr. Learn is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Gastrointestinal Stromal Tumor, Stomach Cancer, Neuroendocrine Tumor, Myringotomy, and Small Bowel Resection. Dr. Learn is currently accepting new patients.

Valerie Lee, M.D., is a medical oncologist with the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, as well as an instructor of medical oncology at Johns Hopkins University School of Medicine. Dr. Lee has an expertise in management of gastrointestinal malignancies, including gastric, colon and pancreatobiliary cancers. Dr. Lee earned her medical degree from the Columbia University College of Physicians and Surgeons. She completed a residency in internal medicine at New York Presbyterian Hospital, followed by a fellowship in medical oncology at the Johns Hopkins University School of Medicine. Dr. Lee is currently earning her Certificate in Science of Clinical Investigation at Johns Hopkins Bloomberg School of Public Health. Dr. Lee is a member of the American Society of Clinical Oncology. Dr. Lee manages multiple early phase trials and her work has been published in peer-reviewed journals. Her research interests include clinical trials for patients with gastrointestinal malignancies, and combining traditional chemotherapies with immunotherapy to improve survival and quality of life for patients. She has received a Cancer Center Training grant for research on molecular targets for cancer detection and treatment and has spoken at numerous conferences on updates in gastrointestinal malignancies. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Pancreaticoduodenectomy.

Timothy Cannon is an Oncologist and a Hematologist in Falls Church, Virginia. Dr. Cannon is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Colorectal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Cholangiocarcinoma (Bile Duct Cancer). Dr. Cannon is currently accepting new patients.

John Marshall is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Marshall is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, Hepatectomy, and Pancreatectomy.

Craig Rezac is a Colorectal Surgeon in Arlington, Virginia. Dr. Rezac is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Familial Colorectal Cancer, Retroperitoneal Inflammation, Colorectal Cancer, Colostomy, and Hernia Surgery.

Robert Reid is a Hematologist and an Oncologist in Fairfax, Virginia. Dr. Reid is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Breast Cancer, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy.

Joanna Klubo is an Endocrinologist in Washington, Washington, D.c.. Dr. Klubo is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Thyroid Cancer, Hypothyroidism, Thyroid Nodule, Thyroidectomy, and Hormone Replacement Therapy (HRT).

Dr. Michael Pishvaian is the director of Gastrointestinal, Developmental Therapeutics and Clinical Research Programs for the Johns Hopkins Kimmel Cancer Center in the Greater Washington Area and an associate professor at the School of Medicine. Dr. Pishvaian is a fellowship-trained gastrointestinal oncologist specializing in pancreatic and refractory colorectal cancers. He is committed to precision medicine and provides his patients with the most appropriate and advanced level of care. He conducts all phases of clinical trials for all GI cancers and enrolls qualifying patients. Click here to learn more about oncology clinical trials the Greater Washington Area. Dr. Pishvaian is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

Marcus Noel is an Oncologist and a Hospital Medicine provider in Washington, Washington, D.c.. Dr. Noel has been practicing medicine for over 18 years and is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Neuroendocrine Tumor, and Tissue Biopsy.

Dr. Michail Mavros, a surgical oncologist specializing in complex cancers, is deeply committed to offering his patients personalized, advanced care. Originally from Athens, Greece, Dr. Mavros's passion for oncology was sparked during medical school after losing a close friend to cancer. This life-changing event inspired him to dedicate his career to improving the lives of cancer patients. Dr. Mavros is one of few surgeons with accredited subspecialty training in both complex surgical oncology and hepato-pancreato-biliary (HPB) surgery, making him highly qualified to treat cancers of the liver, pancreas, and bile ducts. He is also skilled in minimally invasive techniques, including laparoscopic and robotic-assisted surgery, which offer benefits such as faster recovery, reduced pain, and improved outcomes. At the heart of Dr. Mavros' approach is his belief in individualized care. He works closely with a multidisciplinary team of experts, including medical oncologists, radiation oncologists, and pathologists, to ensure each patient receives a thorough evaluation. This collaborative approach results in comprehensive, personalized treatment plans. By leveraging the latest advances in precision medicine, Dr. Mavros tailors his treatments to meet the unique needs of each patient, guided by the most current scientific research and evidence-based practices. Dr. Mavros is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Familial Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Splenectomy.

Stephen R. Broderick, M.D., MPHS, is an assistant professor of surgery at Johns Hopkins University School of Medicine and a thoracic surgeon, part of a multidisciplinary team treating lung cancer patients in the Johns Hopkins Kimmel Cancer Center. Listen to Dr. Broderick's Cancer Matters podcast episode to learn more about his work. Dr. Broderick's primary clinical focus is at Sibley Memorial Hospital, in Washington, D.C. He also practices at The Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center in Baltimore, Maryland. Dr. Broderick has a clinical expertise in surgical treatment of lung cancer, esophageal cancer and other thoracic malignancies, as well as benign thoracic conditions. This includes achalasia, bronchoscopy, chest wall reconstruction and tumors, lung nodules and paraesophageal hernias. He has a clinical interest in minimally invasive surgery for lung cancer and the coordinated delivery of multidisciplinary care for thoracic oncology patients. Before joining Johns Hopkins, Dr. Broderick was a thoracic surgeon at St Luke’s Hospital, where he served as the medical director of the cardiothoracic intensive care unit and a member of the oncology steering committee. He also served as an instructor of surgery at Washington University School of Medicine. Dr. Broderick received his medical degree from Georgetown University School of Medicine in 2003 and he completed his internship and residency training in general surgery at New York-Presbyterian Hospital. He studied the molecular biology of lung cancer as a research fellow at Memorial Sloan Kettering Cancer Center, where he received the Chairman's Award for outstanding contributions to the basic science research fellowship. Dr. Broderick also completed a fellowship in thoracic surgery at Washington University School of Medicine in 2012 and earned a Masters in Population Health Science from Washington University School of Medicine in 2014. Dr. Broderick is a member of the American College of Chest Physicians, The Society of Thoracic Surgeons and the American Society of Clinical Oncology. Dr. Broderick’s research interests are focused on improving outcomes for lung cancer patients. He is particularly interested in studying how various treatments for early-stage lung cancer impact patients’ quality of life. Dr. Broderick has contributed to numerous publications and is a reviewer for the Journal of Cardiovascular and Thoracic Surgery, as well as Annals of Thoracic Surgery. Dr. Broderick is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Nodules, Tubal Ligation, and Lung Transplant.

Keeran Sampat is a Hematologist and an Oncologist in Arlington, Virginia. Dr. Sampat is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Anal Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Paget Disease of the Breast.

Oliver Chen is a Radiologist in Falls Church, Virginia. Dr. Chen has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Ascites, Neuroendocrine Tumor, Pleurisy, Osteotomy, and Advanced Bronchoscopy.

Aaron Stack is a Nuclear Medicine specialist and a Radiologist in Annandale, Virginia. Dr. Stack is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Primary Lymphoma of the Brain, Classical Hodgkin Lymphoma, Neuroendocrine Tumor, and Lung Nodules.

Dr. Susan Scott is a thoracic medical oncologist with the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center at Sibley Memorial Hospital and Assistant Professor of Oncology at the Johns Hopkins University School of Medicine. Dr. Scott has expertise in thoracic malignancies, including non-small cell lung cancer, small cell lung cancer and pulmonary carcinoid tumors, as well as thymic malignancies. She leads the EGFR and HER2 lung cancer research program for Johns Hopkins. Dr. Scott received her undergraduate education at the University of Oxford, UK and medical doctorate from Yale University. She completed residency at the Cleveland Clinic where she also served as Chief Resident in Internal Medicine. Dr. Scott joined Johns Hopkins Oncology for fellowship training in Baltimore and was recruited to the thoracic oncology program to continue work as a physician and clinical scientist focused in lung cancer. Dr. Scott and her team are committed to providing compassionate and individualized care to their patients, including state-of-the-art therapies and clinical trials. Her research interests include clinical trials in resectable lung cancer, innovative applications of immunotherapy, and novel targeted therapies, especially EGFR- and HER2-mutated lung cancers. Dr. Scott is a member of the American Society of Clinical Oncology (ASCO), the American Association of Cancer Research (AACR), and the International Association for the Study of Lung Cancer (IASLC). Dr. Scott is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and EGFR Positive Lung Cancer.

Dr. Benjamin Levy is a thoracic medical oncologist and the clinical director of medical oncology for the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, as well as an associate professor of oncology for Johns Hopkins University School of Medicine. He practices out of the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital. Dr. Levy is a physician scientist who is interested in innovative immunotherapeutic approaches for advanced stage lung cancer patients and biomarkers that help define those patients more likely to respond to such agents. He has an expertise in thoracic malignancies, including non-small cell lung cancer, small cell lung cancer and thymic malignancies, as well as head and neck cancer. Dr. Levy earned his medical degree from Medical College of Georgia. He completed an internal medicine residency at Georgetown University Hospital, followed by a hematology/oncology fellowship at New York Presbyterian/Weill Cornell Medical Center, where he received the Department of Medicine Research Fellow of the Year Award and the 2009 American Society of Clinical Oncology Young Investigator Award for his clinical research in prostate cancer. Dr. Levy previously worked as an assistant professor at the Icahn School of Medicine, medical director of thoracic oncology for Mount Sinai Health Systems and associate director of the Cancer Clinical Trials Office for Mount Sinai Hospital in New York City. Dr. Levy played an integral role on several American Society of Clinical Oncology (ASCO) committees and currently serves as associate editor for the ASCO University Committee. He completed a two year term on the editorial board for the Journal of Clinical Oncology and currently serves as an ad hoc reviewer for other journals, including Clinical Lung Cancer, The Oncologist and Oncotarget. Dr. Levy was recently selected as one of only 15 oncologists in the country to the prestigious ASCO Leadership Development program, whose mission is to identify and develop future leaders of ASCO. In addition to his ASCO commitments, Dr. Levy serves on the ALLIANCE Respiratory Committee, the IASLC Staging Committee and the IASLC Career Development & Fellowship Committee. Dr. Levy is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma.

Khaled M. El-Shami, M.B.Ch.B., Ph.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology in the Division of Hematologic Malignancies at Johns Hopkins University School of Medicine. Listen to Dr. El-Shami's Cancer Matters podcast episode to learn more about his work. Dr. El-Shami's clinical interests are in hematologic malignancies, including leukemias, lymphomas and myelomas.. Dr. El-Shami graduated from Alexandria University Faculty of Medicine in Alexandria, Egypt, where he did a residency in the Department of Neurosurgery. He was a Chevening Scholar as a M.S. student in molecular genetics at the University of Sussex in the United Kingdom, as well as a Sam Cohen Windhoek Scholar as a Ph.D. student in cancer immunology at the Weizmann Institute in Israel. Dr. El-Shami also completed a residency in internal medicine at George Washington University School of Medicine, a fellowship in tumor immunology and biology at the National Cancer Institute, and a fellowship in medical oncology at Johns Hopkins University School of Medicine. Dr. El-Shami previously served as faculty at Georgetown University and George Washington University. Dr. El-Shami has been named a Top Doctor by Washingtonian Magazine for several years. Dr. El-Shami is a member of the American Association for Advancement of Science, the American Association of Cancer Research, the American Association of Immunologists, the American Society for Gene Therapy and the American Society of Clinical Oncology. Dr. El-Shami's research focus is on hematologic malignancies, including acute and chronic leukemias, myelodysplastic syndromes, myeloprolifetive neplasms and lymphomas. He has received the National Institutes of Health Clinical Research Scholars Award, an American Medical Association Seed Grant and an American Society of Clinical Oncology Merit Award. Dr. El is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.